Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The incidence and prevalence of neuroendocrine tumors (NETs) are thought to be rising, but updated epidemiologic data are lacking.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): JAMA Oncol

Title: JAMA oncology

Publisher: American Medical Association (AMA)

ISSN (Electronic): 2374-2445

ISSN (Print): 2374-2437

Publication date (Electronic): Oct 01 2017

Volume: 3

Issue: 10

Affiliations

[1 ] Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.

[2 ] Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston.

[3 ] Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston.

Article

Publisher Item ID: 2621997

DOI: 10.1001/jamaoncol.2017.0589

PubMed ID: 28448665

SO-VID: a722759d-ca87-4e9e-b672-bf736793a852

History

Data availability:

Comments

Comment on this article

scite_

Cited by 1,069

See all cited by

- Version 1
- Version 1